SCILEX HOLDING CO

Profile

Company Names

SCILEX HOLDING CO

Addresses

960 SAN ANTONIO ROAD, PALO ALTO, CA 94303

Phone Numbers

(650) 516-4310

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$104,563,540.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-09-30 
$2,688,540.00 
$2,688,540.00 
$0.00 
 
1
2023-09-21 
$101,875,000.00 
$101,875,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAY 
 
CHUN 
DIRECTOR
SCILEX HOLDING CO
DORMAN 
 
FOLLOWWILL 
DIRECTOR
SCILEX HOLDING CO
HENRY 
 
JI 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  QUIKBYTE SOFTWARE INC   |  SORRENTO THERAPEUTICS, INC.   |  CONKWEST, INC.   |  CELULARITY INC.   |  AARDVARK THERAPEUTICS, INC.   |  SCILEX HOLDING CO
DAVID 
 
LEMUS 
DIRECTOR
CELULARITY INC.   |  SCILEX HOLDING CO
STEPHEN 
 
MA 
EXECUTIVE OFFICER, DIRECTOR
SCILEX HOLDING CO
JAISIM 
 
SHAH 
EXECUTIVE OFFICER, DIRECTOR
ZELOS THERAPEUTICS INC   |  ELEVATION PHARMACEUTICALS INC   |  SEMNUR PHARMACEUTICALS, INC.   |  SORRENTO THERAPEUTICS, INC.   |  CELULARITY INC.   |  SCILEX HOLDING CO
YUE 
ALEXANDER 
WU 
DIRECTOR
CROWN BIOSCIENCE, INC   |  SCILEX HOLDING CO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-14
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
 
2025-09-30 
2023-10-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
Debt 
2023-09-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#